Clinical Trials Browser

Phase 3 × Enrolling by invitation × OTHER × Clear all

NCT07348575 2026-01-16

A Multicenter, Prospective, Randomized, Controlled Study of Decitabine in Combination With R-CHOP for Initial Treatment of EBV+ Diffuse Large B-cell Lymphoma

Phase 3 Enrolling by invitation

Lymphoma, Large B-Cell, Diffuse

NCT07311057 2026-01-06

Investigation of Effect of Formulated Methylene Blue on Treatment of Squamous Cell Carcinoma Skin Cancer in Inoperable Patients and Not Suitable for Radiotherapy

Phase 3 Enrolling by invitation

Carcinoma, Carcinoma, Squamous Cell

NCT07311070 2026-01-06

Treatment of Basal Cell Carcinoma (BCC) of the Skin, of the Morpheiform, Infiltrative, and Noduloulcerative Types in Inoperable Patients and Not Suitable for Radiotherapy Using Formulated Methylene Blue

Phase 3 Enrolling by invitation

Carcinoma, Basal Cell

NCT07258680 2025-12-02

BrEto-TCL

Phase 3 Enrolling by invitation

Lymphoma, T-Cell, Peripheral

NCT07149506 2025-09-08

OCTOPUS-RD

Phase 3 Enrolling by invitation

Fibrosis, Radiodermatitis

NCT06950190 2025-08-12

(ECCPC)

Phase 3 Enrolling by invitation

Chemotherapy-Related Cognitive Impairment, Neurotoxicity Syndromes, Cognitive Dysfunction

NCT07084454 2025-07-24

GAIN-S

Phase 3 Enrolling by invitation

Depression

NCT07016737 2025-06-12

ESO-Nanjing12

Phase 3 Enrolling by invitation

Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT03507842 2025-03-17

A Prospective Randomized Comparison of HDAC Vs AD in the Induction Chemothrapy for AML.

Phase 3 Enrolling by invitation

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT06857305 2025-03-04

Efficacy and Safety of Biweekly Regimen of Eribulin Versus a Standard Regimen for the Treatment of Locally Recurrent or Metastatic HER2-negative Breast Cancer: a Multicenter, Randomized, Open-label, Phase III Trial

Phase 3 Enrolling by invitation

Breast Cancer Metastatic

NCT05674539 2025-02-10

Reduced Intensity Conditioning Regimens for Acute Myeloid Leukemia and Myelodysplastic Syndrome

Phase 3 Enrolling by invitation

MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT06671418 2024-11-04

TESLA RCT

Phase 3 Enrolling by invitation

Gastrointestinal

Gallbladder Neoplasms